| Document Date: 2014-11-15 15:50:29
Open Document File Size: 218,30 KBShare Result on Facebook
City DURHAM / / Company Chimerix Inc. / Wellcome Trust / / Facility University of Oxford / / / IndustryTerm biopharmaceutical / biopharmaceutical company developing novel / / MedicalCondition smallpox / infection / CMV infection / often-fatal viral infection / Ebola Virus Disease / herpes / / Organization World Health Organization / Biomedical Advanced Research and Development Authority / U.S. Food and Drug Administration / University of Oxford / / Person M. Michelle Berrey / / / Position President and Chief Executive Officer / / ProvinceOrState North Carolina / / Region West Africa / / URL www.chimerix.com / /
SocialTag |
Chimerix’s Brincidofovir Selected for Use in Ebola Clinical Trial in West Africa by International Consortium DURHAM, N.C., November 13, [removed]Chimerix, Inc. (NASDAQ: CMRX), a biopharmaceutical company developing nove